Is DMPWW or ORCC a better dividend investment in 2026?

DMPWW currently yields 2000000.00% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: DMPWW offers higher current income.

What is the dividend yield difference between DMPWW and ORCC?

DMPWW has a forward dividend yield of 2000000.00% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 1999990.21 percentage points.

Home › Compare › DMPWW vs ORCC

DMPWW vs ORCC: Dividend Comparison 2026

DMPWW yields 2000000.00% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DMPWW wins by $1.6247481716182984e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DMPWW

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.6247481716182984e+23M

Annual income

$147,608,011,402,949,780,000,000,000,000.00

Full DMPWW calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — DMPWW vs ORCC

📍 DMPWW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DMPWW	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DMPWW + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DMPWW pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMPWW

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$125,466,809,692,507,310,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, DMPWW beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMPWW + ORCC for your $10,000?

DMPWW: 50%ORCC: 50%

100% ORCC50/50100% DMPWW

Portfolio after 10yr

$8.123740858091492e+22M

Annual income

$73,804,005,701,474,890,000,000,000,000.00/yr

Blended yield

90.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

DMPWW

No analyst data

Altman Z

-32.8

Piotroski

3/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMPWW buys

ORCC buys

No recent congressional trades found for DMPWW or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDMPWWORCC

Forward yield	2000000.00% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	-50%
Portfolio after 10y	$1.6247481716182984e+23M	$21.4K ✓
Annual income after 10y	$147,608,011,402,949,780,000,000,000,000.00 ✓	$1.04
Total dividends collected	$1.6146053563276882e+23M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: DMPWW vs ORCC ($10,000, DRIP)

Year	DMPWW Portfolio	DMPWW Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,190	$489.61	+$100.00M → DMPWW
2	$467,446,731,075	$467,339,719,626.17	$12,229	$256.01	+$467446.72M → DMPWW
3	$1,021,215,363,816,662	$1,020,715,195,814,411.90	$13,216	$130.74	+$1021215363.80M → DMPWW
4	$1,043,112,617,104,109,200	$1,042,019,916,664,825,300.00	$14,207	$66.02	+$1043112617104.09M → DMPWW
5	$498,482,143,759,731,400,000	$497,366,013,259,430,040,000.00	$15,234	$33.17	+$498482143759731.38M → DMPWW
6	$111,599,275,650,097,780,000,000	$111,065,899,756,274,860,000,000.00	$16,317	$16.62	+$111599275650097776.00M → DMPWW
7	$11,738,678,336,351,557,000,000,000	$11,619,267,111,405,953,000,000,000.00	$17,468	$8.32	+$11738678336351557632.00M → DMPWW
8	$583,674,362,697,175,100,000,000,000	$571,113,976,877,278,900,000,000,000.00	$18,695	$4.16	+$583674362697175072768.00M → DMPWW
9	$13,894,210,989,607,547,000,000,000,000	$13,269,679,421,521,570,000,000,000,000.00	$20,006	$2.08	+$1.3894210989607547e+22M → DMPWW
10	$162,474,817,161,829,840,000,000,000,000	$147,608,011,402,949,780,000,000,000,000.00	$21,407	$1.04	+$1.6247481716182984e+23M → DMPWW

DMPWW vs ORCC: Complete Analysis 2026

DMPWW — Stock

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Full DMPWW Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this DMPWW vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMPWW vs SCHD DMPWW vs JEPI DMPWW vs O DMPWW vs KO DMPWW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.